Published in Naunyn Schmiedebergs Arch Pharmacol on January 01, 2001
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci (2007) 1.29
The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.17
Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium. Br J Pharmacol (2002) 1.15
Tools to study beta3-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.14
Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers. Naunyn Schmiedebergs Arch Pharmacol (2004) 1.12
Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.09
Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor. Br J Pharmacol (2002) 1.08
Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery. Br J Pharmacol (2003) 1.07
The 'state' of beta-adrenoceptors. Br J Pharmacol (2003) 1.02
Do low-affinity states of beta-adrenoceptors have roles in physiology and medicine? Br J Pharmacol (2004) 1.01
Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.00
A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors. PLoS One (2010) 0.99
Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout. Br J Pharmacol (2008) 0.99
Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system. J Mol Cell Cardiol (2010) 0.98
Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats. Br J Pharmacol (2004) 0.98
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling. Trends Pharmacol Sci (2011) 0.97
Evidence against beta 3-adrenoceptors or low affinity state of beta 1-adrenoceptors mediating relaxation in rat isolated aorta. Br J Pharmacol (2003) 0.94
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta. Br J Pharmacol (2004) 0.93
Overexpression of beta 1-adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation: implications for 'putative' beta 4-adrenoceptor pharmacology. Br J Pharmacol (2004) 0.92
Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms. Br J Pharmacol (2008) 0.91
Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors. J Med Chem (2011) 0.89
Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.88
Challenges in β(3)-Adrenoceptor Agonist Drug Development. Ther Adv Endocrinol Metab (2011) 0.88
Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle. Br J Pharmacol (2006) 0.86
beta-adrenoceptors and potassium channels. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.86
Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats. Br J Pharmacol (2005) 0.86
Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart. Br J Pharmacol (2002) 0.85
Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure? Pflugers Arch (2007) 0.85
Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor. Mol Pharmacol (2014) 0.85
β3-adrenoceptors inhibit stimulated norepinephrine release in spontaneously hypertensive rats. Front Physiol (2014) 0.83
A study of antagonist affinities for the human histamine H2 receptor. Br J Pharmacol (2007) 0.82
The influence of diabetes on cardiac beta-adrenoceptor subtypes. Heart Fail Rev (2007) 0.82
Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP. Br J Pharmacol (2014) 0.82
Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation. FASEB J (2015) 0.82
Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues. Br J Pharmacol (2003) 0.82
Are [O-methyl-11C]derivatives of ICI 89,406 beta1-adrenoceptor selective radioligands suitable for PET? Eur J Nucl Med Mol Imaging (2007) 0.81
Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze. World J Cardiol (2011) 0.80
Altered β1-3-adrenoceptor influence on α2-adrenoceptor-mediated control of catecholamine release and vascular tension in hypertensive rats. Front Physiol (2015) 0.79
Aspartate138 is required for the high-affinity ligand binding site but not for the low-affinity binding site of the beta1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.78
[On the function of beta3-adrenoceptors in the human heart: signal transduction, inotropic effect and therapeutic prospects]. Wien Med Wochenschr (2006) 0.78
Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis. Br J Pharmacol (2006) 0.77
Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells. BMC Pharmacol (2008) 0.76
Use of a new proximity assay (NanoBRET) to investigate the ligand-binding characteristics of three fluorescent ligands to the human β1-adrenoceptor expressed in HEK-293 cells. Pharmacol Res Perspect (2016) 0.75
Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling. Br J Pharmacol (2013) 0.75
Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.75
Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A (1999) 3.13
Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol (1994) 2.18
Dobutamine-stress magnetic resonance microimaging in mice : acute changes of cardiac geometry and function in normal and failing murine hearts. Circ Res (2001) 2.08
Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J Biol Chem (1993) 1.89
Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol (1999) 1.77
Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science (1996) 1.74
Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science (1996) 1.59
Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol (1997) 1.53
Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Br J Pharmacol (1996) 1.52
Realization of the Hofstadter Hamiltonian with ultracold atoms in optical lattices. Phys Rev Lett (2013) 1.39
Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun (1992) 1.37
Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family. J Biol Chem (1991) 1.34
Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.34
(-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. Mol Pharmacol (1998) 1.26
Black diaphragm aniridia intraocular lens for congenital aniridia: long-term follow-up. J Cataract Refract Surg (2000) 1.25
Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol (2001) 1.19
A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum. Br J Pharmacol (1995) 1.19
Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues. Br J Pharmacol (1987) 1.18
Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program. J Pharmacol Methods (1983) 1.15
Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart. J Pharmacol Exp Ther (1988) 1.12
Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation (1999) 1.12
Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly fire" cohort. J Occup Environ Med (2001) 1.11
A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc Natl Acad Sci U S A (1994) 1.10
Characterization of beta-1 and beta-2 adrenoceptors in guinea pig atrium: functional and receptor binding studies. J Pharmacol Exp Ther (1987) 1.07
Activation and deactivation kinetics of alpha 2A- and alpha 2C-adrenergic receptor-activated G protein-activated inwardly rectifying K+ channel currents. J Biol Chem (2001) 1.07
Management of traumatic lung injury: a Western Trauma Association Multicenter review. J Trauma (2001) 1.04
A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 1.02
The affinity and efficacy of the selective beta 1-adrenoceptor stimulant RO363 at beta 1- and beta 2-adrenoceptor sites. Br J Pharmacol (1984) 1.02
Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. J Cardiovasc Pharmacol (1993) 1.01
Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)- or beta(2)-adrenergic receptors. Mol Pharmacol (2001) 1.00
Is Ro 03-7894 an irreversible antagonist at beta-adrenoceptor sites? Br J Pharmacol (1984) 0.99
Molecular architecture of the human specialised atrioventricular conduction axis. J Mol Cell Cardiol (2011) 0.99
Characterization of beta 1- and beta 2-adrenoceptors in rat skeletal muscles. Biochem Pharmacol (1991) 0.99
The human heart endothelin system: ET-1 synthesis, storage, release and effect. Trends Pharmacol Sci (2000) 0.97
Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice. Neuroscience (2002) 0.97
Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle. Br J Pharmacol (1993) 0.97
Preoperative three-dimensional model creation of magnetic resonance brain images as a tool to assist neurosurgical planning. Stereotact Funct Neurosurg (2013) 0.96
Prourokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins. J Biol Chem (1995) 0.96
Autoradiographic localization of beta-1 and beta-2 adrenoceptors in guinea pig atrium and regions of the conducting system. J Pharmacol Exp Ther (1987) 0.96
Synthesis of substituted 5-fluoro-5,6-dihydropyrimidines. Nucleic Acids Res (1975) 0.96
Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding. Br J Pharmacol (1999) 0.95
Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: blockade with SB 209670. J Pharmacol Exp Ther (2000) 0.95
A dileucine motif in the C terminus of the beta2-adrenergic receptor is involved in receptor internalization. Proc Natl Acad Sci U S A (1997) 0.95
Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the beta1-adrenergic receptor. FASEB J (2001) 0.95
New views of human cardiac beta-adrenoceptors. J Mol Cell Cardiol (1989) 0.95
Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium. Br J Pharmacol (1998) 0.94
Occurrence, pharmacology and function of presynaptic alpha2-autoreceptors in alpha2A/D-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.94
Study of interaction between agonists and asn293 in helix VI of human beta(2)-adrenergic receptor. Mol Pharmacol (1999) 0.94
Can we use vertical bore magnetic resonance scanners for murine cardiovascular phenotype characterization? Influence of upright body position on left ventricular hemodynamics in mice. J Cardiovasc Magn Reson (2001) 0.94
Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with alpha(2) adrenergic receptors. Neuroscience (2004) 0.92
Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice. Br J Pharmacol (2001) 0.91
Bicarbonate attenuates intracellular acidosis. Acta Anaesthesiol Scand (2002) 0.91
The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther (1998) 0.91
2',3'=Carbonates in the synthesis of uridine 5'-deoxy and 2',5'-dideoxy derivatives. Nucleic Acids Res (1976) 0.90
Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice. Br J Pharmacol (2006) 0.90
Modulation of vascular development and injury by angiotensin II. Cardiovasc Res (1999) 0.89
Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor. Circulation (2001) 0.89
Expression, purification, and characterization of the cGMP-dependent protein kinases I beta and II using the baculovirus system. FEBS Lett (1995) 0.89
Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists. Br J Pharmacol (1998) 0.88
The incidence of transient neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supine position. Hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5%. Acta Anaesthesiol Scand (2000) 0.87
Alpha2-adrenoceptor-mediated inhibition of cultured sympathetic neurons: changes in alpha2A/D-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.86
The use of magnetic resonance imaging to assess slow fluid flow in a model cerebrospinal fluid shunt system. Br J Neurosurg (1990) 0.86
Diacylglycerol kinase η modulates oncogenic properties of lung cancer cells. Clin Transl Oncol (2013) 0.86
Characterization and localization of atypical beta-adrenoceptors in rat ileum. Br J Pharmacol (1995) 0.86
Murine ventricular L-type Ca(2+) current is enhanced by zinterol via beta(1)-adrenoceptors, and is reduced in TG4 mice overexpressing the human beta(2)-adrenoceptor. Br J Pharmacol (2001) 0.85
Postnatal development of presynaptic receptors that modulate noradrenaline release in mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.85
Stimulation frequency-noradrenaline release relationships examined in alpha2A-, alpha2B- and alpha2C-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.83
Mechanisms of beta-adrenergic receptor desensitization: from molecular biology to heart failure. Basic Res Cardiol (1996) 0.83
Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition. J Thromb Haemost (2013) 0.82
Autoradiographic localization of receptors in the mammalian cardiovascular system. Clin Exp Pharmacol Physiol (1987) 0.82
Necrotizing fasciitis as complication of injection into greater trochanteric bursa. Am J Orthop (Belle Mead NJ) (2001) 0.82
Teleform: a blessing or burden? Public Health Nurs (2000) 0.82
Pertussis toxin does not inhibit the alpha 1-adrenoceptor-mediated effect on inositol phosphate production in the heart. Eur J Pharmacol (1987) 0.82
Suppression of cellular immune activity following severe head injury. J Neurotrauma (1990) 0.81
Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann N Y Acad Sci (1993) 0.81
Cimaterol reduces beta-adrenergic receptor density in rat skeletal muscles. J Anim Sci (1992) 0.81
Evidence for internalization of both type 1 angiotensin receptor subtypes (AT1a, AT1b) by a protein kinase C independent mechanism. Hypertens Res (1997) 0.81
Ventricular tachycardia with ECT. J ECT (1998) 0.80
Chronic (-)-isoprenaline infusion down-regulates beta 1- and beta 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.80
Analysis of agonist dissociation constants as assessed by functional antagonism in guinea pig left atria. J Pharmacol Methods (1986) 0.80
Magnetic resonance imaging analysis of extremely slow flow in a model shunt system. Childs Nerv Syst (1992) 0.80
Organization of the human annexin V (ANX5) gene. Genomics (1994) 0.80
Alpha(2A)-adrenoceptors regulate sympathetic transmitter release in mice kidneys. Br J Pharmacol (2006) 0.80
Clinical and experimental observations in patients with congenital myasthenic syndromes. Ann N Y Acad Sci (1993) 0.80
In vivo mutation of the alpha 2A-adrenergic receptor by homologous recombination reveals the role of this receptor subtype in multiple physiological processes. Adv Pharmacol (1998) 0.80
Solubilization and partial characterization of phospholipase A from rat heart sarcoplasmic reticulum. Biochim Biophys Acta (1988) 0.80
Timing of urgent thoracotomy for hemorrhage after trauma: a multicenter study. Arch Surg (2001) 0.79
Contribution of beta-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and beta(3)-adrenoceptor knockout mice. Br J Pharmacol (2000) 0.79
A multi-scale modelling approach for analysing landscape service dynamics. J Environ Manage (2012) 0.79
Influence of assay buffer on dissociation constants of drugs at beta-adrenoceptor subtypes. Eur J Pharmacol (1985) 0.79
Videodensitometric estimation of the protective effect of hyperbaric oxygen in the ischemic gerbil brain. Surg Neurol (1985) 0.79
Evaluation of recombinant tissue plasminogen activator in embolic stroke. Neurosurgery (1989) 0.78
Limb salvage for streptococcal gangrene of the extremity. Am J Surg (1998) 0.78
Protein kinase a transgenes: the many faces of cAMP. Circ Res (2001) 0.78
Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice. Acta Physiol (Oxf) (2014) 0.78
Effect of chemical sympathectomy on (-)-isoprenaline-induced changes in cardiac beta-adrenoceptor subtypes in the guinea-pig and rat. J Auton Pharmacol (1994) 0.77
Beta 2-adrenoreceptor binding sites in circular and longitudinal myometrial layers of the virgin guinea-pig: the influence of ovarian steroids. J Auton Pharmacol (1986) 0.77
Effect of the novel 5-HT4 receptor agonist DAU 6236 in human colon. Med J Aust (1994) 0.77